{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:52:35Z","timestamp":1777056755027,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2011,6,21]],"date-time":"2011-06-21T00:00:00Z","timestamp":1308614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1245\/s10434-011-1830-0","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T17:08:11Z","timestamp":1308589691000},"page":"3824-3827","source":"Crossref","is-referenced-by-count":19,"title":["Is Neo-adjuvant Chemotherapy a \u201cWaiver\u201d of Extensive Upper Abdominal Surgery in Advanced Epithelial Ovarian Cancer?"],"prefix":"10.1245","volume":"18","author":[{"given":"Sokbom","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo Heon","family":"Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Ha","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myong Cheol","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Soo","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-Woo","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Yoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,21]]},"reference":[{"key":"1830_CR1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","volume":"55","author":"A Jemal","year":"2005","unstructured":"Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10\u201330.","journal-title":"CA Cancer J Clin."},{"key":"1830_CR2","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248\u201359.","journal-title":"J Clin Oncol."},{"key":"1830_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3802\/jgo.2010.21.2.75","volume":"21","author":"KK Shih","year":"2010","unstructured":"Shih KK, Chi DS. Maximal cytoreductive effort in epithelial ovarian cancer surgery. J Gynecol Oncol. 2010;21:75\u201380.","journal-title":"J Gynecol Oncol."},{"key":"1830_CR4","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","volume":"21","author":"RF Ozols","year":"2003","unstructured":"Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol. 2003;21:3194\u2013200.","journal-title":"J Clin Oncol."},{"key":"1830_CR5","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1245\/s10434-009-0558-6","volume":"16","author":"S Kang","year":"2009","unstructured":"Kang S, Nam BH. Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies. Ann Surg Oncol. 2009;16:2315\u201320.","journal-title":"Ann Surg Oncol."},{"key":"1830_CR6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/gyno.1998.5236","volume":"72","author":"PE Schwartz","year":"1999","unstructured":"Schwartz PE, Rutherford TJ, Chambers JT, McAlpine JN, Azodi M, Rutherford TJ, et al. Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival. Gynecol Oncol. 1999;72:93\u20139.","journal-title":"Gynecol Oncol."},{"key":"1830_CR7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","volume":"363","author":"I Vergote","year":"2010","unstructured":"Vergote I, Trope CG, Amant F, Kristensen GB, Ehlen T, Johnson N, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010;363:943\u201353.","journal-title":"N Engl J Med."},{"key":"1830_CR8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1053\/beog.2002.0304","volume":"16","author":"PE Schwartz","year":"2002","unstructured":"Schwartz PE. Neoadjuvant chemotherapy for the management of ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2002;16:585\u201396.","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"1830_CR9","first-page":"1615","volume":"19","author":"I Vergote","year":"2005","unstructured":"Vergote I, van Gorp T, Amant F, Neven P, Berteloot P. Neoadjuvant chemotherapy for ovarian cancer. Oncology (Williston Park). 2005;19:1615\u201322 (discussion 1623\u201330).","journal-title":"Oncology (Williston Park)"},{"key":"1830_CR10","first-page":"387","volume":"134","author":"T Gorp Van","year":"2007","unstructured":"Van Gorp T, Amant F, Neven P, Berteloot P, Leunen K, Vergote I. The role of neoadjuvant chemotherapy versus primary surgery in the management of stage III ovarian cancer. Cancer Treat Res. 2007;134:387\u2013402.","journal-title":"Cancer Treat Res."},{"key":"1830_CR11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1525-1438.2001.01064.x","volume":"11","author":"F Kayikcioglu","year":"2001","unstructured":"Kayikcioglu F, Kose MF, Boran N, Cali\u015fkan E, Tulunay G. Neoadjuvant chemotherapy or primary surgery in advanced epithelial ovarian carcinoma. Int J Gynecol Cancer. 2001;11:466\u201370.","journal-title":"Int J Gynecol Cancer."},{"key":"1830_CR12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1447-0756.2006.00359.x","volume":"32","author":"SJ Lee","year":"2006","unstructured":"Lee SJ, Kim BG, Lee JW, Park CS, Lee JH, Bae DS. Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery. J Obstet Gynaecol Res. 2006;32:99\u2013106.","journal-title":"J Obstet Gynaecol Res."},{"issue":"Suppl 2","key":"1830_CR13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1525-1438.2003.13354.x","volume":"13","author":"M Baekelandt","year":"2003","unstructured":"Baekelandt M. The potential role of neoadjuvant chemotherapy in advanced ovarian cancer. Int J Gynecol Cancer. 2003;13 Suppl 2:163\u20138.","journal-title":"Int J Gynecol Cancer"},{"key":"1830_CR14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2407-6-153","volume":"6","author":"A Inciura","year":"2006","unstructured":"Inciura A, Simavicius A, Juozaityte E, Kurtinaitis J, Nadisauskiene R, Svedas E, et al. Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer: a retrospective study of 574 patients. BMC Cancer. 2006;6:153.","journal-title":"BMC Cancer"},{"key":"1830_CR15","first-page":"25","volume":"27","author":"T Giannopoulos","year":"2006","unstructured":"Giannopoulos T, Butler-Manuel S, Taylor A, Ngeh N, Thomas H. Clinical outcomes of neoadjuvant chemotherapy and primary debulking surgery in advanced ovarian carcinoma. Eur J Gynaecol Oncol. 2006;27:25\u20138.","journal-title":"Eur J Gynaecol Oncol."},{"key":"1830_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2010.09.010","volume":"120","author":"GD Aletti","year":"2011","unstructured":"Aletti GD, Eisenhauer EL, Santillan A, Axtell A, Aletti G, Holschneider C, et al. Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment. Gynecol Oncol. 2011;120:23\u20138.","journal-title":"Gynecol Oncol."},{"key":"1830_CR17","doi-asserted-by":"crossref","first-page":"676 e1","DOI":"10.1016\/j.ajog.2007.10.495","volume":"197","author":"GD Aletti","year":"2007","unstructured":"Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol. 2007;197:676 e1\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"1830_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jso.21398","volume":"101","author":"S Kang","year":"2010","unstructured":"Kang S, Kim TJ, Nam BH, Seo SS, Kim BG, Bae DS, et al. Preoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: a meta-analysis. J Surg Oncol. 2010;101:13\u20137.","journal-title":"J Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-011-1830-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-011-1830-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-011-1830-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T16:43:18Z","timestamp":1572972198000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-011-1830-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,21]]},"references-count":18,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1830"],"URL":"https:\/\/doi.org\/10.1245\/s10434-011-1830-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,21]]}}}